Clinical Trial Update: Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome) [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing conversion from immediate-release to controlled-release ropinirole for Restless Legs Syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Ropinirole (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Restless Legs Syndrome, Restless Legs Syndrome (RLS) | Phase 3 | Status: COMPLETED | Results posted: 2019-03-15